# Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00219648** · PHASE2 · UNKNOWN · sponsor: **PharmaEngine**

## Conditions studied

- COPD

## Interventions

- **DRUG:** PEP03

## Key facts

- **NCT ID:** NCT00219648
- **Lead sponsor:** PharmaEngine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219648, "Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00219648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*